329
Participants
Start Date
November 16, 2018
Primary Completion Date
July 29, 2019
Study Completion Date
August 22, 2019
Baricitinib
Administered orally.
Topical corticosteroid
Administered as standard-of-care.
Placebo
Administered orally.
Chang Gung Memorial Hospital - Linkou, Taoyuan, (r.o.c.)
Skin & Cancer Foundation Australia, Westmead
Woden Dermatology, Phillip
Skin and Cancer Foundation Inc., Melbourne
Veracity Clinical Research Pty Ltd, Woolloongabba
The Skin Centre, Benowa
Clinical Trials SA Pty Ltd, Adelaide
Parra Dermatología, Mendoza
Fremantle Dermatology, Perth
Universitätsklinikum Graz, Graz
National Taiwan University Hospital, Taipei
Charité Universitätsmedizin Berlin, Berlin
Dongguk University Ilsan Hospital, Goyang-si
Chang Gung Memorial Hospital - Taipei, Taipei
Hospital Reina Sofia, Córdoba
Korea University Ansan Hospital, Ansan-si
Azienda Ospedaliera Universitaria Ospedale San Martino di Genova, Genova
Istituto Clinico Humanitas, Rozzano
TFS Trial Form Support GmbH, Hamburg
Gachon University Gil Medical Center, Incheon
Universitätsklinikum Schleswig-Holstein, Lübeck
Taipei Medical University- Shuang Ho Hospital, New Taipei City
Hospital Universitario Ramon y Cajal, Madrid
Hospital De Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria
ULSS 8 UOC Dermatologia Viale Rodolfi, 37, Vicenza
Chung Shan Medical University Hospital, Taichung
Universitaetsklinikum Essen, Essen
Universitätsklinikum Münster, Münster
Dermatologisches Zentrum Osnabrück Nord, Bramsche
Universitätsklinikum Aachen - UKA, Aachen
Azienda Ospedaliera - Universitaria Pisana, Pisa
Rosenpark Research Geschäftsbereich der Rosenparkklinik GmbH, Darmstadt
Universitätsklinikum Heidelberg, Heidelberg
Klinikum der Universität München, München
Chang Gung Memorial Hospital - Kaohsiung, Kaohsiung City
Shirasaki Clinic, Takaoka-shi
Centro de Investigaciones Metabólicas (CINME) - Comite, Ciudad Autonoma Buenos Aires
Fundacion CIDEA, Ciudad Autonoma Buenos Aires
Instituto de Neumonología y Dermatología, Ciudad Autonoma Buenos Aires
Psoriahue Medicina Interdisciplinaria, Ciudad Autonoma Buenos Aires
Policlinico Univ. Agostino Gemelli, Rome
Kawashima Dermatology Clinic, Ichikawa-shi
Medical Corporation Soleil Miyata Dermatology Clinic, Matsudo-shi
Yamano Dermatological Clinic, Dazaifu
Tashiro Dermatological Clinic, Iizuka
Shibaki Dermatology Clinic, Sapporo
Sapporo Skin Clinic, Sapporo
Queen's Square Dermatology and Allergology, Nishi-ku, Yokohama-city
Yoshioka Dermatology Clinic, Neyagawa
Senri-Chuo Hanafusa Dermatology Clinic, Toyonaka-shi
JA Shizuoka Kohseiren Enshu Hospital, Hamamatsu
Iidabashi Clinic, Chiyoda-ku
Tokyo Teishin Hospital, Chiyoda-Ku
Hosono Clinic, Chuo-ku
Oizumi Hanawa Clinic, Nerima-ku
Yamate Dermatological Clinic, Shinjuku
Tachikawa Dermatology Clinic, Tachikawa-shi
Dermed Centrum Medyczne Sp. z o.o., Lodz
Lubelskie Centrum Diagnostyczne, Świdnik
Centrum Medyczne AMED, Warsaw
Centrum Medyczne Evimed, Warsaw
Severance Hospital Yonsei University Health System, Seoul
Konkuk University Hospital, Seoul
Seoul St. Mary's Hospital, Seoul
Chungang University Hospital, Seoul
Hallym University Kangnam Sacred Heart Hospital, Seoul
Hospital del Mar, Barcelona
Hospital de la Santa Creu i Sant Pau, Barcelona
Collaborators (1)
Incyte Corporation
INDUSTRY
Eli Lilly and Company
INDUSTRY